Immunotherapy leverages the bodyâs immune system as a stimulus to fight cancer. Treatments such as checkpoint inhibitors and CAR-T cell therapy stimulate the immune system to recognize and attack cancer cells. These therapies have shown promise in treating various cancers, including melanoma and certain types of leukemia. By understanding how to harness and direct these internal stimuli, researchers aim to develop more effective and personalized cancer treatments.
